A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer

Epithelial ovarian cancer (EOC) is the most common gynecologic malignancy. To identify the micro-ribonucleic acids (miRNAs) expression profile in EOC tissues that may serve as a novel diagnostic biomarker for EOC detection, the expression of 1722 miRNAs from 15 normal ovarian tissue samples and 48 ovarian cancer samples was profiled by using a quantitative real-time polymerase chain reaction (qRT-PCR) assay. A ten-microRNA signature (hsa-miR-1271-5p, hsa-miR-574-3p, hsa-miR-182-5p, hsa-miR-183-5p, hsa-miR-96-5p, hsa-miR-15b-5p, hsa-miR-182-3p, hsa-miR-141-5p, hsa-miR-130b-5p, and hsa-miR-135b-3p) was identified to be able to distinguish human ovarian cancer tissues from normal tissues with 97% sensitivity and 92% specificity. Two miRNA clusters of miR183-96-183 (miR-96-5p, and miR-182, miR183) and miR200 (miR-141-5p, miR200a, b, c and miR429) are significantly up-regulated in ovarian cancer tissue samples compared to those of normal tissue samples, suggesting theses miRNAs may be involved in ovarian cancer development.

[1]  P. Meltzer,et al.  A p21-ZEB1 Complex Inhibits Epithelial-Mesenchymal Transition through the MicroRNA 183-96-182 Cluster , 2013, Molecular and Cellular Biology.

[2]  Jun Li,et al.  Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. , 2012, Oncology reports.

[3]  Yong Huang,et al.  Biological functions of MicroRNAs , 2010, Russian Journal of Bioorganic Chemistry.

[4]  P. Schiff,et al.  Fertility preservation in young women with epithelial ovarian cancer , 2009, Cancer.

[5]  Xiaofei Xu,et al.  The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. , 2013, The international journal of biochemistry & cell biology.

[6]  D. Marsh,et al.  Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer , 2012, BMC Cancer.

[7]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[8]  P. Wimberger,et al.  microRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment? , 2012, Clinical chemistry and laboratory medicine.

[9]  Rende Guo,et al.  MicroRNA‐182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas , 2013, Journal of cellular biochemistry.

[10]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[11]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[12]  G. Dimattia,et al.  BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation , 2012, Clinical & Experimental Metastasis.

[13]  I. Jacobs,et al.  The UKCTOCS Experience—Reasons for Hope? , 2012, International Journal of Gynecologic Cancer.

[14]  M. Gore,et al.  Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G. Samimi,et al.  Epigenetic biomarkers in epithelial ovarian cancer. , 2014, Cancer letters.

[16]  L. De Cecco,et al.  Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. , 2010, The international journal of biochemistry & cell biology.

[17]  A. Whittemore,et al.  Patterns and Progress in Ovarian Cancer Over 14 Years , 2006, Obstetrics and gynecology.

[18]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[19]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[20]  Zhaojian Liu,et al.  MiR‐182 overexpression in tumourigenesis of high‐grade serous ovarian carcinoma , 2012, The Journal of pathology.

[21]  Xiaowei Wang.  A PCR-based platform for microRNA expression profiling studies. , 2009, RNA.

[22]  Zhihui Feng,et al.  A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. , 2009, Gynecologic oncology.

[23]  M. King,et al.  Inherited breast and ovarian cancer. , 1995, Human molecular genetics.

[24]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[25]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[26]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[27]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.